Underexpression of RhoH in hairy cell leukemia

Cancer Research

Volumn 68, Issue 12, 2008, Pages 4531-4540

  Galiègue Zouitina, Sylvie ^a   Delestré, Laure ^a   Dupont, Caroline ^a   Troussard, Xavier ^b   Shelley, Carl Simon ^a,c,d  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHO KINASE; GLYCOPROTEIN P 15095; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOH PROTEIN, HUMAN; RHOH PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CHRONIC DISEASE; DRUG SCREENING; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; LEUKOCYTE; LYMPHOMA; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; SPLEEN; SPLEEN TUMOR; THROMBOCYTHEMIA; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11C; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHRONIC DISEASE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, HAIRY CELL; LEUKOCYTES; LYMPHOCYTES; LYMPHOMA; MALE; MICE; MICE, SCID; PROMOTER REGIONS (GENETICS); RHO GTP-BINDING PROTEINS; SPLEEN; SPLENIC NEOPLASMS; THROMBOCYTHEMIA, HEMORRHAGIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 49649086768     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5661     Document Type: Article

References (49)

1. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 1958;13:609-30.
2. Allsup DJ, Cawley JC. Diagnosis, biology and treatment of hairy-cell leukaemia. Clin Exp Med 2004;4:132-8.
3. Platanias LC, Golomb HM. Hairy cell leukaemia. Baillieres Clin Haematol 1993;6:887-98.
4. Robak T. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev 2006;32:365-76.
5. Mey U, Strehl J, Gorschluter M, et al. Advances in the treatment of hairy-cell leukaemia. Lancet Oncol 2003;4:86-94.
6. Zypchen LN, Nantel SH, Barnett J, Noble M, Gascoyne RD, Connors JM. Cladribine does not cure hairy cell leukemia (HCL) [ASH abstract 1593]. Blood 2003.
7. Golde DW, Stevens RH, Quan SG, Saxon A. Immunoglobulin synthesis in hairy cell leukemia. Br J Haematol 1977;35:359-65.
8. Saxon A, Stevens RH, Golde DW. T-lymphocyte varient of hairy-cell leukemia. Ann Int Med 1978;88:323-6.
9. Schwarting R, Stein H, Wang CY. The monoclonal antibodies αS-HCL1 (αLeu-14) and αS-HCL3 (αLeu-M5) allow the diagnosis of hairy cell leukemia. Blood 1985;65:974-83.
10. Yam LT, Li CY, Lam KW. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med 1971;284:357-60.
11. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037-50.
12. Lam KW, Li O, Li CY, Yam LT. Biochemical properties of human prostatic acid phosphatase. Clin Chem 1973;19:483-7.
13. Nicolaou F, Teodoridis JM, Park H, et al. CD11c gene expression in hairy-cell leukemia is dependent upon activation of the proto-oncogenes ras and junD. Blood 2003;101:4033-41.
14. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20:2390-400.
15. Abate C, Patel L, Rauscher FJ III, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990;249:1157-61.
16. Boyle WJ, Smeal T, Defize LHK, et al. Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell 1991;64:573-84.
17. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 1987;49:729-39.
18. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of proto-oncogene JUN/Ap-1 by serum and TPA. Nature 1988;334:629-31.
19. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/ Ap-1. Cell 1988;55:875-85.
20. Wilson T, Treisman R. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature 1988;336:396-9.
21. Nakamura T, Datta R, Kharbanda S, Kufe D. Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor. Cell Growth Differ 1991;2:267-72.
22. Abate C, Luk D, Curran T. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly. Cell Growth Differ 1990;1:455-62.
23. Abate C, Luk D, Gentz R, Rauscher FJ III, Curran T. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc Natl Acad Sci U S A 1990;87:1032-6.
24. Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 1992;11:653-65.
25. Harvey WH, Harb OS, Kosak ST, Sheaffer JC, Lowe LR, Heerema NA. Interferon-α-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Leuk Res 1994;18:577-85.
26. Dallery E, Galiègue-Zouitina S, Collyn-d'Hooghe M, et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3, 4) chromosomal translocation. Oncogene 1995;10:2171-8.
27. Dallery-Prudhomme E, Roumier C, Denis C, Preudhomme C, Kerckaert JP, Galiègue-Zouitina S. Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization. Genomics 1997;1:89-94.
28. Li X, Bu X, Lu B, Avraham H, Flavell RA, Lim B. The hematopoietic- specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol 2002;22:1158-71.
29. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005;105:1467-75.
30. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
31. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965;18:522-9.
32. Adams RA, Flowers A, Davis BJ. Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2. Cancer Res 1968;28:1121-5.
33. Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyo EM, Klein E. Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 1969;23:64-79.
34. Pulvertaft JV. Cytology of Burkitt's tumor (African lymphoma). Lancet 1964;39:238-40.
35. Nilsson K, Bennich H, Johansson SG, Ponten J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol 1970;7:477-89.
36. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 1993;5:66-70.
37. Nacheva E, Dyer MJ, Fischer P, et al. C-MYC translocations in de novo B-cell lineage acute leukemias with t(14; 18; cell lines Karpas 231 and 353). Blood 1993;82:231-40.
38. Schiller JH, Bittner G, Meisner LF, et al. Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient. Leukemia 1991;5:399-407.
39. Faguet GB, Satya-Prakash KL, Agee JF. Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines. Blood 1988;71:422-9.
40. Harvey W, Srour EF, Turner R, et al. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation. Leuk Res 1991;15:733-44.
41. Kontula K, Paavonen T, Vuopio P, Andersson LC. Glucocorticoid receptors in hairy-cell leukemia. Int J Cancer 1982;30:423-6.
42. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-90.
43. Shelley CS, Farokhzad OC, Arnaout MA. Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene. Proc Natl Acad Sci U S A 1993;90:5364-8.
44. Shelley CS, Teodoridis JM, Park H, Farokhzad OC, Böttinger EP, Arnaout MA. During Differentiation of the monocytic cell line U937, Pura mediates induction of the CD11c gene promoter. J Immunol 2002;168:3887-93.
45. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of "real-time" quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program. Leukemia 2003;17:2318-57.
46. Lahousse S, Smorowski AL, Denis C, Lantoine D, Kerckaert JP, Galiègue-Zouitina S. Structural features of hematopoiesis-specific RhoH/ARHH gene: high diversity of 5′-UTR in different hematopoietic lineages suggests a complex post-transcriptional regulation. Gene 2004;343:55-68.
47. Cherry LK, Li X, Schwab P , Lim B, Klickstein LB. RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes. Nat Immunol 2004;5:961-7.
48. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. Leukocyte adhesion during hypoxia is mediated by HIF-1 dependent induction of β2 integrin gene expression. Proc Natl Acad Sci U S A 2004;101:10440-5.
49. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005;386:193-205.